US OptionsDetailed Quotes

PAY241115C25000

Watchlist

2.47
-0.08-3.14%

15min DelayClose Nov 1 16:00 ET

2.75High2.47Low

Paymentus Holdings Stock Discussion

Stanlley

Jul 25 21:10

$Paymentus Holdings (PAY.US)$ This stock expect to rise after the earning report day

Bigmoney Dreamer

Mar 14 19:42

$Paymentus Holdings (PAY.US)$ 👀awaitng 17dip

Movers and Shakers

Mar 5 07:27

Columns Today's Morning Movers and Top Ratings: AMD, AAPL, TSLA, TGT and More

Morning Movers
Gapping up
$Target (TGT.US)$ The retailer's stock climbed nearly 8% after reporting fourth-quarter earnings that exceeded analysts' expectations, with earnings of $2.98 per share on $31.92 billion in revenue, higher than the expected $2.42 per share on $31.83 billion in revenue as surveyed by LSEG.
$Paymentus Holdings (PAY.US)$ The stock jumped 19.6% after the payment technology company reported a fourth-quarter ea...

Moomoo AI

Feb 21 10:47

Paymentus Holdings' high P/S ratio is backed by robust future revenue predictions. Shareholders' confidence in the company's future revenues is keeping the P/S ratio elevated. Unless analysts have grossly miscalculated, these strong revenue forecasts should sustain the share price.

What You Can Learn From Paymentus Holdings, Inc.'s (NYSE:PAY) P/S

Moomoo AI

Nov 8, 2023 08:20

Despite weak recent performance, hopes of better revenue have maintained Paymentus Holdings' high P/S ratio, leading to resilient share prices. The optimistic revenue forecast and slim chances of future decline continue to support the high ratio and share price.

Why We're Not Concerned About Paymentus Holdings, Inc.'s (NYSE:PAY) Share Price

Moomoo Breakfast US

May 5, 2022 07:27

Columns Today's pre-market stock movers: BKNG, TWTR, SHOP, EBAY and more

Gainers:
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...

No comment yet